These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7517969)

  • 1. Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A2.
    Schneider T; Lang AB; Carballido JM; Santamaria Babi LF; Dudler T; Kägi MK; Blaser K; Suter M
    J Allergy Clin Immunol; 1994 Jul; 94(1):61-70. PubMed ID: 7517969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antibody response to bee venom phospholipase A2 induced by natural exposure in humans or by immunization in mice.
    Schneider T; Dudler T; Annand RR; Gelb MH; King TP; Suter M
    J Mol Recognit; 1997; 10(2):93-100. PubMed ID: 9376132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of murine monoclonal antibodies to phospholipase A2 and mellitin from bee venom.
    Müller WD; Fahlbusch B; Jung K; Gebhardt M; Jäger L
    Int Arch Allergy Immunol; 1993; 101(2):153-8. PubMed ID: 7685217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine residues in bee venom phospholipase A2 are important for binding to human monoclonal or polyclonal antibodies of the IgG4 isotope.
    Schneider T; Dudler T; Gelb MH; Suter M
    Int Arch Allergy Immunol; 1994 Jul; 104(3):262-9. PubMed ID: 7518267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by competitive inhibition in ELISA.
    Rieben R; Blaser K
    J Immunol Methods; 1989 Apr; 119(1):1-8. PubMed ID: 2708823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells.
    Akdis CA; Blesken T; Akdis M; Alkan SS; Wüthrich B; Heusser CH; Blaser K
    J Allergy Clin Immunol; 1997 Mar; 99(3):345-53. PubMed ID: 9058690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
    Gomi H; Tagaya Y; Nakano T; Mikayama T; Ishizaka K
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2824-8. PubMed ID: 7511819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic surface of the bee venom allergen phospholipase A2. Structural functional analysis of human IgG4 antibodies reveals potential role in protection.
    Dudler T; Schneider T; Annand RR; Gelb MH; Suter M
    J Immunol; 1994 Jun; 152(11):5514-22. PubMed ID: 8189069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific interaction of IgE antibodies with a carbohydrate epitope of honey bee venom phospholipase A2.
    Weber A; Schröder H; Thalberg K; März L
    Allergy; 1987 Aug; 42(6):464-70. PubMed ID: 2444130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution-phase binding of monoclonal antibodies to bee venom phospholipase A2.
    Myatt EA; Stevens FJ; Benjamin C
    J Immunol Methods; 1994 Dec; 177(1-2):35-42. PubMed ID: 7822836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.
    Blaser K
    Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants and mechanisms of human immune responses to bee venom phospholipase A2.
    Blaser K; Carballido J; Faith A; Crameri R; Akdis C
    Int Arch Allergy Immunol; 1998 Sep; 117(1):1-10. PubMed ID: 9751842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
    Mori A; Thomas P; Tagaya Y; Iijima H; Grey H; Ishizaka K
    Int Immunol; 1993 Aug; 5(8):833-42. PubMed ID: 7691164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-independent suppression of the IgE immune response to bee venom phospholipase A2 by maternally derived monoclonal IgG antibodies.
    Seeger M; Thierse HJ; Lange H; Shaw L; Hansen H; Lemke H
    Eur J Immunol; 1998 Jul; 28(7):2124-30. PubMed ID: 9692881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune response to bee venom. Comparison of the antibody response to phospholipase A2 with the response to inhalant antigens.
    Kemeny DM; Miyachi S; Platts-Mills TA; Wilkins S; Lessof MH
    Int Arch Allergy Appl Immunol; 1982; 68(3):268-74. PubMed ID: 7085123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotype-associated recognition of allergen epitopes and its modulation by antigen dose.
    Kolbe L; Heusser CH; Kölsch E
    Immunology; 1995 Feb; 84(2):285-9. PubMed ID: 7538490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM; MacKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy.
    Devey ME; Lee SR; Richards D; Kemeny DM
    J Allergy Clin Immunol; 1989 Sep; 84(3):326-30. PubMed ID: 2778238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
    Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K
    J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.